UE
SEC Insider//CIK 0001306267
Unkart Edward W
CIK 00013062673 companiesFRAMINGHAM, MA
Transactions
40
Companies
3
Filings
11
CIK
0001306267
Recent Transactions
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Award
- Award
- Award
- Award
Employee Stock Option (right to buy)
2022-10-13+10,000→ 10,000 total - Award
Director Stock Option (Right to Buy)
2021-09-30+10,000→ 10,000 total - Award
Director Stock Option (right to buy)
2020-10-01+7,000→ 7,000 total - Award
Director Stock Option (Right to Buy)
2019-10-02$11.21/sh+7,000→ 7,000 total - Award
Director Stock Option (Right to Buy)
2018-10-03+7,000→ 7,000 total - Award
Director Stock Option (Right to Buy)
2017-09-27+6,000→ 6,000 total - Award
Director Stock Option (Right to Buy)
2017-03-23+12,000→ 12,000 total - Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition from Tender
- Disposition to Issuer
- Disposition to Issuer
- Exercise/Conversion
- Exercise/Conversion
- Award
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Award
- Exercise/Conversion
- Exercise/Conversion
- Award
- Conversion
- Conversion
- Award
Companies
3Recent Filings
11- 4
Unkart Edward W
Jun 11, 2026
- 4
Unkart Edward W
Oct 2, 2025
- 4
Unkart Edward W
Oct 4, 2024
- 4
Unkart Edward W
Sep 28, 2023
- 4
Unkart Edward W
Oct 17, 2022
- 4
Unkart Edward W
Oct 1, 2021
- 4
Unkart Edward W
Oct 2, 2020
- 4
Unkart Edward W
Oct 3, 2019
- 4
Unkart Edward W
Oct 5, 2018
- 4
Unkart Edward W
Sep 29, 2017
- 4
KalVista Pharmaceuticals, Inc.
Mar 27, 2017
Address
C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD
FRAMINGHAM, MA, 01702